ArticleFrontiers in aging neuroscience2026
Privacy and personalisation: predicting Parkinson's disease severity from real-world gait with federated learning.
Article in Frontiers in aging neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Decision-centered wearable biosensors for personalized rehabilitation: integrating multimodal monitoring, artificial intelligence, and closed-loop intervention.Frontiers in bioengineering and biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cloud-based artificial intelligence (AI) combined with smart-health technology presents a powerful tool to passively monitor disease severity. However, current methods raise privacy concerns as they require transmitting patient data to the cloud. A potential solution is Federated Learning (FL), which only shares the weights of locally trained neural networks (NNs) instead of user data. Here, we simulated an FL system to demonstrate its application for evaluating Parkinson's disease (PD) severity in a smart-home scenario. Methods: Retrospective data including 89 people with PD wore an accelerometer on the lower-back at home for 7 days at 18-month intervals over 6 years. Patient characteristics (age, sex, and body mass index) and clinical measures of PD were additionally collected, including the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS)-Part III. Real-world daily gait measures along with these patient characteristics were used to predict the MDS-UPDRS-III score. For FL, a local model was trained for each participant, and a global model (an aggregation of these local models) was tested on unseen participants. Results: The performance of a simulated FL system was compared with that of a traditional Machine Learning (ML) approach in which patient data were shared. The traditional ML approach had a mean absolute error (MAE) of 10.43. The global FL model had a similar MAE of 10.22 but was underfitted, and the mean MAE of the local, personalised models was 4.83. Shapley Additive exPlanations (SHAP) analysis showed that while the participants' age and sex were very important in traditional ML, this was not the case for the local FL models, leading to a decrease in global model performance. Here, we show that reserving a small number of participants from the system and including them in training data for all local models restored the importance of these features and improved global FL performance (MAE = 9.26) but reduced local performance (MAE = 6.83). Conclusion: This exploratory study shows that our proposed approach enables FL to achieve similar accuracy to traditional Machine Learning without sharing any patient data but with costs to the local performance, leading towards a smart-home system that prioritises personalisation and patient privacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.